methamphetamine has been researched along with aripiprazole in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Koob, GF; Pulvirenti, L; Wang, Z; Wee, S; Woolverton, WL | 1 |
| Abad, A; Anderson, A; Condos, R; De La Garza, R; Elkashef, A; Halkitis, PN; Li, SH; Mahoney, JJ; Mojisak, J; Newton, TF; Palamar, J; Reid, MS | 1 |
| Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W | 1 |
| Inada, K; Ishigooka, J; Oshibuchi, H; Sugawara, H | 1 |
| Akiyama, S; Forbes, A; Futamura, T; Kikuchi, T; McQuade, RD; Sugino, H | 1 |
| Chen, CH; Cheng, MC; Hsu, SH | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 1 |
| Hashimoto, K; Iyo, M; Kanahara, N; Okamura, N; Sekine, Y; Tadokoro, S | 1 |
| Glaser, PE; Hays, LR; Rush, CR; Sevak, RJ; Stoops, WW; Vansickel, AR | 1 |
| Gill, JS; Guan, NC; Hussein, HM; Said, MA; Sulaiman, AH; Zainal, NZ | 1 |
| Coffin, PO; Colfax, GN; Das, M; Gasper, J; Huffaker, S; Matheson, T; Santos, DM; Santos, GM; Vittinghoff, E | 1 |
| Bennett, JA; Lile, JA; Rush, CR; Sevak, RJ; Stoops, WW | 1 |
| Correll, CU; Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Habata, Y; Imaichi, S; Komatsu, H; Maruyama, M; Mori, M; Sakuma, K | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
4 review(s) available for methamphetamine and aripiprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of methamphetamine addiction: an update.
Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders | 2008 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome | 2013 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
3 trial(s) available for methamphetamine and aripiprazole
| Article | Year |
|---|---|
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Area Under Curve; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Cues; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Methamphetamine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Socioeconomic Factors | 2008 |
A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Behavior, Addictive; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Patient Compliance; Piperazines; Psychoses, Substance-Induced; Quinolones | 2013 |
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Aripiprazole; Combined Modality Therapy; Counseling; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Medication Adherence; Methamphetamine; Piperazines; Quinolones; Substance Abuse Detection; Treatment Failure | 2013 |
10 other study(ies) available for methamphetamine and aripiprazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration.
Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Aripiprazole; Brain; Brain Chemistry; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Nucleus Accumbens; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Self Administration | 2007 |
Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
Topics: Amygdala; Animals; Antipsychotic Agents; Aripiprazole; Central Nervous System Stimulants; Conditioning, Psychological; Dopamine; Dopamine D2 Receptor Antagonists; Electric Stimulation; Fear; Haloperidol; Male; Methamphetamine; Microdialysis; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stress, Psychological | 2009 |
Aripiprazole attenuates established behavioral sensitization induced by methamphetamine.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Central Nervous System Stimulants; Dopamine Antagonists; Male; Methamphetamine; Mice; Motor Activity; Piperazines; Quinolones; Random Allocation; Sulpiride | 2010 |
Repetitive administration of aripiprazole enhances locomotor response to methamphetamine in mice.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Piperazines; Quinolones | 2011 |
Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Behavioral Symptoms; Disease Models, Animal; Dizocilpine Maleate; Haloperidol; In Situ Nick-End Labeling; Inhibition, Psychological; Male; Methamphetamine; Microdialysis; Motor Activity; Neuroprotective Agents; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2011 |
Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Long-Term Care; Male; Methamphetamine; Motor Activity; Piperazines; Psychoses, Substance-Induced; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2012 |
Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole.
Topics: Aripiprazole; Blood Pressure; Discrimination Learning; Female; Heart Rate; Humans; Male; Methamphetamine; Piperazines; Psychomotor Performance; Quinolones; Surveys and Questionnaires; Young Adult | 2011 |
Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Blood Pressure; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Rate; Humans; Male; Methamphetamine; Piperazines; Quinolones; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2013 |
Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Dizocilpine Maleate; Gene Expression Profiling; Gene Expression Regulation; Hallucinogens; Haloperidol; Methamphetamine; Mice; Olanzapine; Phencyclidine; Receptors, Dopamine D2 | 2015 |